A shared five biomarker profile across four major neurodegenerative diseases

The Global Neurodegeneration Proteomics Consortium (GNPC) has published a series of research papers detailing their efforts to identify patterns in neurodegenerative disease. Sifting through roughly 250 million plasma measurements, they have discovered a five-protein panel present in APOE ε4 carriers across Alzheimer’s disease, Parkinson’s disease, frontotemporal dementia and amyotrophic lateral sclerosis.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup